95556-7
Adrenal cancer risk assessment and urine steroid fractions panel
Active
Term Description
A risk assessment based on patient clinical data combined with biochemical steroid results to assess the probability of a malignant adrenal cortical carcinoma (ACC) or other malignancy (e.g. sarcoma, lymphoma) versus the probability of a benign mass (e.g. adenoma, myelolipoma, cyst). Clinical biomarkers may include age at diagnosis, gender, mode of discovery, hormonal status (e.g. overproduction), tumor diameter, and density of the tumor by CT.
Source: Regenstrief LOINC
Panel Hierarchy
Details for each LOINC in Panel LHC-Forms
LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
---|---|---|---|---|
95556-7 | Adrenal cancer risk assessment and urine steroid fractions panel | |||
Indent95787-8 | Adrenal cortical carcinoma probability [Likelihood] based on clinical data | % | ||
Indent95788-6 | Adrenal malignancy other than ACC probability [Likelihood] based on clinical data | % | ||
Indent95789-4 | Benign mass probability [Likelihood] based on clinical data | % | ||
Indent95790-2 | Adrenal cortical carcinoma probability [Likelihood] based on clinical and lab data | % | ||
Indent95791-0 | Adrenal malignancy other than ACC probability [Likelihood] based on clinical and lab data | % | ||
Indent95792-8 | Benign mass probability [Likelihood] based on clinical and lab data | % | ||
Indent73884-9 | Steroid fractions interpretation in 24 hour Urine Narrative | |||
Indent63932-8 | Age at diagnosis | a | ||
Indent46098-0 | Sex | |||
Indent95557-5 | Detection basis of Tumor | |||
Indent21889-1 | Size Tumor | mm | ||
Indent95558-3 | CT attenuation of adrenal mass | [hnsf'U] | ||
Indent95559-1 | Evidence of adrenal cortical hormone excess [Presence] in 24 hour Urine | |||
Indent13362-9 | Collection duration of Urine | h | ||
Indent3167-4 | Volume of 24 hour Urine | L | ||
Indent95571-6 | 11-Deoxytetrahydrocorticosterone [Mass/time] in 24 hour Urine | ug/(24.h) | ||
Indent95572-4 | 11-Deoxytetrahydrocorticosterone [Z-score] in 24 hour Urine | {Zscore} | ||
Indent6701-7 | 11-Hydroxyandrosterone [Mass/time] in 24 hour Urine | mg/(24.h) | ||
Indent95584-9 | 11-Hydroxyandrosterone [Z-score] in 24 hour Urine | {Zscore} | ||
Indent6700-9 | 11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine | mg/(24.h) | ||
Indent95585-6 | 11-Hydroxyetiocholanolone [Z-score] in 24 hour Urine | {Zscore} | ||
Indent6703-3 | 11-Ketoetiocholanolone [Mass/time] in 24 hour Urine | mg/(24.h) | ||
Indent95564-1 | 16-Alpha hydroxydehydroepiandrosterone [Z-score] in 24 hour Urine | {Zscore} | ||
Indent95591-4 | 11-Ketoetiocholanolone [Z-score] in 24 hour Urine | {Zscore} | ||
Indent95563-3 | 16-Alpha hydroxydehydroepiandrosterone [Mass/time] in 24 hour Urine | ug/(24.h) | ||
Indent95575-7 | 17 Alpha-hydroxypregnanolone [Z-score] in 24 hour Urine | {Zscore} | ||
Indent95574-0 | 17 Alpha-hydroxypregnanolone [Mass/time] in 24 hour Urine | ug/(24.h) | ||
Indent95582-3 | 5-Alpha tetrahydrocortisol [Z-score] in 24 hour Urine | {Zscore} | ||
Indent21044-3 | 5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine | ug/(24.h) | ||
Indent95568-2 | 5-Pregnenediol [Z-score] in 24 hour Urine | {Zscore} | ||
Indent95567-4 | 5-Pregnenediol [Mass/time] in 24 hour Urine | ug/(24.h) | ||
Indent95566-6 | 5-Pregnenetriol [Z-score] in 24 hour Urine | {Zscore} | ||
Indent95565-8 | 5-Pregnenetriol [Mass/time] in 24 hour Urine | ug/(24.h) | ||
Indent13611-9 | 6-Beta-Hydroxycortisol [Mass/time] in 24 hour Urine | ug/(24.h) | ||
Indent95580-7 | 6-Beta-Hydroxycortisol [Z-score] in 24 hour Urine | {Zscore} | ||
Indent55906-2 | Alpha cortolone [Mass/time] in 24 hour Urine | mg/(24.h) | ||
Indent95588-0 | Alpha cortolone [Z-score] in 24 hour Urine | {Zscore} | ||
Indent6705-8 | Androsterone [Mass/time] in 24 hour Urine | mg/(24.h) | ||
Indent95560-9 | Androsterone [Z-score] in 24 hour Urine | {Zscore} | ||
Indent53634-2 | Beta cortol [Mass/time] in 24 hour Urine | ug/(24.h) | ||
Indent95590-6 | Beta cortolone [Z-score] in 24 hour Urine | {Zscore} | ||
Indent95583-1 | Beta cortol [Z-score] in 24 hour Urine | {Zscore} | ||
Indent95589-8 | Beta cortolone [Mass/time] in 24 hour Urine | ug/(24.h) | ||
Indent14158-0 | Cortisol [Mass/time] in 24 hour Urine | ug/(24.h) | ||
Indent95579-9 | Cortisol [Z-score] in 24 hour Urine | {Zscore} | ||
Indent95586-4 | Cortisone [Z-score] in 24 hour Urine | {Zscore} | ||
Indent14044-2 | Cortisone [Mass/time] in 24 hour Urine | ug/(24.h) | ||
Indent95562-5 | Dehydroepiandrosterone (DHEA) [Z-score] in 24 hour Urine | {Zscore} | ||
Indent13612-7 | Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine | mg/(24.h) | ||
Indent95561-7 | Etiocholanolone [Z-score] in 24 hour Urine | {Zscore} | ||
Indent2268-1 | Etiocholanolone [Mass/time] in 24 hour Urine | mg/(24.h) | ||
Indent2834-0 | Pregnanediol [Mass/time] in 24 hour Urine | mg/(24.h) | ||
Indent95573-2 | Pregnanediol [Z-score] in 24 hour Urine | {Zscore} | ||
Indent2836-5 | Pregnanetriol [Mass/time] in 24 hour Urine | mg/(24.h) | ||
Indent95576-5 | Pregnanetriol [Z-score] in 24 hour Urine | {Zscore} | ||
Indent95577-3 | Pregnanetriolone [Z-score] in 24 hour Urine | {Zscore} | ||
Indent50643-6 | Pregnanetriolone [Mass/time] in 24 hour Urine | ug/(24.h) | ||
Indent95569-0 | Tetrahydro-11-corticosterone [Mass/time] in 24 hour Urine | ug/(24.h) | ||
Indent95570-8 | Tetrahydro-11-corticosterone [Z-score] in 24 hour Urine | {Zscore} | ||
Indent2995-9 | Tetrahydrocortisol [Mass/time] in 24 hour Urine | mg/(24.h) | ||
Indent95581-5 | Tetrahydrocortisol [Z-score] in 24 hour Urine | {Zscore} | ||
Indent16116-6 | Tetrahydrocortisone [Mass/time] in 24 hour Urine | ug/(24.h) | ||
Indent95587-2 | Tetrahydrocortisone [Z-score] in 24 hour Urine | {Zscore} | ||
Indent2996-7 | Tetrahydrodeoxycortisol [Mass/time] in 24 hour Urine | mg/(24.h) | ||
Indent95578-1 | Tetrahydrodeoxycortisol [Z-score] in 24 hour Urine | {Zscore} |
Fully-Specified Name
- Component
- Adrenal cancer risk assessment & urine steroid fractions panel
- Property
- -
- Time
- -
- System
- ^Patient
- Scale
- -
- Method
Additional Names
- Short Name
- Adrenal ca risk assess+ur steroid Pnl
- Display Name
- Adrenal cancer risk assessment and urine steroid fractions panel
- Consumer Name Alpha Get Info
- Adrenal cancer risk assessment and urine steroid fractions panel
Basic Attributes
- Class
- PANEL.CHEM
- Type
- Laboratory
- First Released
- Version 2.69
- Last Updated
- Version 2.69
- Order vs. Observation
- Order
- Panel Type
- Panel
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Evaluación del riesgo de cáncer suprarrenal y panel de fracciones de esteroides en orina: |
es-MX | Spanish (Mexico) | Evaluación del riesgo de cáncer suprarrenal y panel de fracciones de esteroides en orina: |
fr-FR | French (France) | Évaluation du risque de cancer surrénalien et fractions des stéroïdes urinaires panel: |
it-IT | Italian (Italy) | Cancro surrenale valutazione del rischio & frazioni steroidei urinarie, panel: Synonyms: Chimica Panel frazioni di steroidi Panel valutazione del rischio del cancro surrenale e frazioni steroidei urinarie paziente Set di prescrizione chimica Surrene |
zh-CN | Chinese (China) | 肾上腺癌风险评估与尿液类固醇成分组套: Synonyms: 分数类 分级 分级分离 分部分离 分馏 分馏(Fractionation) 分馏型(经分馏的)类固醇类药物(类固醇激素、 |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=95556-7 - Questionnaire definition
- https:
//fhir.loinc.org/Questionnaire/?url=http: //loinc.org/q/95556-7
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright